Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-09-27 00:00:00 ET · period of report 2021-09-25 · accession 0001517026-21-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-27 | 2021-09-25+ | MYGN | Verratti Mark | Pres, Myriad Neuroscience | F - Tax | $33.31 | -10.3K | 205.9K | -5% | -$341.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-26 | F | D | 3,514 | $33.31 | 202,359 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-25 | F | D | 6,746 | $33.31 | 205,873 | D | — | — |